Filing Flows › GoodRx Holdings (GDRX) › Q3 2025
GoodRx Holdings (GDRX) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 4, 2025
GoodRx Holdings (GDRX) reported revenue of $196M for the third quarter 2025 (Q3 2025), +0.4% from a year earlier and -3% from the quarter before. Operating margin was 7.5%, net earnings $1.1M (0.6% of revenue).
GoodRx Holdings, Q3 2025: revenue $196M (+0.4% year over year), operating margin 7.5%, net earnings $1.1M, operating cash flow $76.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $196M | -3% | +0.4% |
| Operating profit | $14.6M | -45% | -28% |
| Net earnings | $1.1M | -91% | -72% |
| Operating cash flow | $76.0M | +53% | -12% |
| Free cash flow | $74.3M | +51% | -14% |
What changed
Revenue was $196.0M in Q3 2025, roughly flat year over year and down 3% from the previous quarter. Prescription transactions revenue was the largest line at 65% of revenue. Pharma manufacturer solutions revenue added $15.2M year over year (up 54%), 1961% of the total change. Other revenue declined 14%.
Operating profit was $14.6M, a 7.5% margin (down 3.0 points year over year). Operating profit fell $5.8M even though revenue rose $777K versus a year earlier, so costs grew faster than sales. Total costs grew 4% against flat revenue. The fastest-growing cost line was General & admin (+25%). Net earnings were $1.1M, down 72% year over year. The effective tax rate was 81.7%.
Operating cash flow was $76.0M (down 12% year over year), 6794% of net earnings. Non-cash charges added back $21.4M of depreciation and amortization and $18.1M of share-based compensation. Working capital and other items added $35.4M. Capital expenditures of $1.7M left free cash flow of $74.3M.
Questions
What was GoodRx Holdings' revenue in the third quarter 2025?
GoodRx Holdings (GDRX) reported revenue of $196M for the third quarter 2025 (Q3 2025), +0.4% from a year earlier and -3% from the quarter before.
Was GoodRx Holdings profitable in the third quarter 2025?
Operating profit was $14.6M (7.5% of revenue) and net earnings $1.1M.
Source: GoodRx Holdings 10-Q on SEC EDGAR.